These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7678314)

  • 21. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the role of aprotinin in heart transplantation.
    Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
    Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with the CorLink device for proximal anastomosis of the saphenous vein to the aorta: a clinical, prospective, and randomized study.
    Riess FC; Helmold H; Hilfer I; Bader R; Stripling J; Loewer C; Wesner F; Bleese N
    Heart Surg Forum; 2002; 5(4):345-53. PubMed ID: 12538116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization.
    Kalangos A; Tayyareci G; Prêtre R; Di Dio P; Sezerman O
    Eur J Cardiothorac Surg; 1994; 8(12):651-6. PubMed ID: 7535064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.
    Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
    Goldman S; Zadina K; Moritz T; Ovitt T; Sethi G; Copeland JG; Thottapurathu L; Krasnicka B; Ellis N; Anderson RJ; Henderson W;
    J Am Coll Cardiol; 2004 Dec; 44(11):2149-56. PubMed ID: 15582312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery.
    Manchio JV; Gu J; Romar L; Brown J; Gammie J; Pierson RN; Griffith B; Poston RS
    Ann Thorac Surg; 2005 Jun; 79(6):1991-8. PubMed ID: 15919298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
    Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
    Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-graft patency and clinical efficacy of aprotinin in elective bypass surgery.
    Lass M; Simic O; Ostermeyer J
    Cardiovasc Surg; 1997 Dec; 5(6):604-7. PubMed ID: 9423946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries.
    Lytle BW; Loop FD; Taylor PC; Goormastic M; Stewart RW; Novoa R; McCarthy P; Cosgrove DM
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):605-12; discussion 612-4. PubMed ID: 8468995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial.
    Souza DS; Johansson B; Bojö L; Karlsson R; Geijer H; Filbey D; Bodin L; Arbeus M; Dashwood MR
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):373-8. PubMed ID: 16872965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood.
    Havel M; Grabenwöger F; Schneider J; Laufer G; Wollenek G; Owen A; Simon P; Teufelsbauer H; Wolner E
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):807-10. PubMed ID: 7510351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different forms of aprotinin during cardiopulmonary bypass.
    De Bakker A; De Hert S; Vlaeminck R; Delrue G; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(2):45-51. PubMed ID: 7694437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes for off-pump coronary artery bypass grafting in high-risk groups: a historical perspective.
    Moore GJ; Pfister A; Trachiotis GD
    Heart Surg Forum; 2005; 8(1):E19-22. PubMed ID: 15769707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.